KK MACHAVARAM, LM ALMOND… - Clinical …, 2013 - pascal-francis.inist.fr
A Physiologically Based Pharmacokinetic Modeling Approach to Predict Disease―Drug Interactions: Suppression of CYP3A by IL-6 CNRS Inist Pascal-Francis CNRS Pascal and …
KK Machavaram, LM Almond… - Clinical …, 2013 - europepmc.org
Elevated cytokine levels are known to downregulate expression and suppress activity of cytochrome P450 enzymes (CYPs). Cytokine-modulating therapeutic proteins (TPs) used in …
KK Machavaram, LM Almond… - Clinical …, 2013 - pubmed.ncbi.nlm.nih.gov
Elevated cytokine levels are known to downregulate expression and suppress activity of cytochrome P450 enzymes (CYPs). Cytokine-modulating therapeutic proteins (TPs) used in …
A Physiologically Based Pharmacokinetic Modeling Approach to Predict Disease–Drug Interactions: Suppression of CYP3A by IL-6 | CiNii Research CiNii 国立情報学研究所 学術 …
K Machavaram, L Almond… - Clinical …, 2013 - research.manchester.ac.uk
A Physiologically –Based Pharmacokinetic Modelling Approach to Predict Disease-Drug Interactions: Suppression of CYP3A by IL-6. — Research Explorer The University of Manchester …
[引用][C]A Physiologically Based Pharmacokinetic Modeling Approach to Predict Disease―Drug Interactions: Suppression of CYP3A by IL-6
KK MACHAVARAM, LM ALMOND… - Clinical …, 2013 - Nature Publishing Group